Vaccine tested for deadly bacterial meningitis strain

[Guest guest]

My take on the following article published in the Sydney Morning Herald:1-

This article is 'in publication' - not yet printed, which leads me to believe that the article in the SMH was put together due to a Novartis press release though I could be wrong? 2- The study was done in Chile. Need I say more? 3- Every single researcher involved was either a full-time employee of Novartis (the vaccine manufacturer)

or was being paid to participate in this study by Novartis. Do you think the study would have been published if it were not positive for the vaccine? 4- There were 5 groups involved - 4 that got the vaccine at different schedules and one that received a placebo which contained aluminium hydroxide - an extremely toxic substance which means

there really was no placebo (by definition, a placebo must be biologically inert - you can't say that AlHO is in any way biologically inert)> 5- There were approximately 375 people in each of the study groups and only 128 in the so-called control. That is probably OK statistically speaking, but I just wanted to point out the difference.

6- Interestingly, in the 4 study groups, 120 people in the 4 study groups withdrew their consent to continue with the trial. There is no explanation for any of this except an admission that one of them developed an adverse event to the vaccine (juvenile arthritis). I feel that the others only withdrew because they became ill too but that is not covered here and surely, if people withdrew, they should have and would have been interviewed to find out why. It seems suspicious that this information is not revealed in the study. 7- The vaccine was considered successful because people developed antibodies a certain number of weeks after vaccine administration. As we know, the presence of antibodies does not mean that someone is immune - it simply means they've been exposed. 8- 43% of those in the study group and 45% of

those in the 'placebo' group (remember, the placebo is a toxic substance in this case) reported adverse events after the close of the study (170-198 days after receiving their last vaccine). 9- All reports of serious adverse events were judged to not be related to the vaccination. Nothing to see here; nothing to worry about. Just keep moving and whatever you do - don't think! So once again, a study by a drug company that does not use a real control and leaves more

question then it does answers, is released and the media reports this drug to be a success when it hasn't even been used or independently tested. This is the state of today's 'science'. Is it any wonder that 40% of Australia's children and 50% of the children in the US are currently being treated for at least 1 chronic condition?http://www.smh.com.au/national/health/vaccine-tested-for-deadly-bacterial-meningitis-strain-20120118-1q6lb.html"These new vaccines represent a major step forward" ... Jim Buttery.A VACCINE has been developed against the last unpreventable strain of bacterial meningitis, which affects hundreds of Australians each year and can be life-threatening.Children are vaccinated against meningococcal C but there is no vaccine against the B strain, which is the most deadly type and can kill in less than four hours. A total of 182 cases of meningococcal B were recorded in Australia last year, and 174 in 2010. It caused eight deaths in 2009, the most recent year for which national figures were available, when there were 198 recorded cases.Melbourne's Royal Children's Hospital infectious diseases physician Jim Buttery said a safe and effective vaccine for meningococcal B would be a significant development particularly for children under two and teenagers, who were most at risk.''This has been one of the real challenges for vaccine researchers for a long time,'' he said.''Compared to the other meningococcal groups, the sugar on the outside of the bug is close to sugar in the human brain, so it can be hard for the human immune system to form immunity against it.''These new vaccines represent a major step forward, and are the first to show real promise.''Dr Buttery said the bug was commonly found in the nose and throat but could cause an invasive infection in people without sufficient immunity.Findings published in British medical journal The Lancet show a meningococcal B vaccine tested in toddlers, teenagers and adults was highly effective and safe.The vaccine, called 4CMenB, was expected to be licensed for use in Europe in the next few months before being evaluated for inclusion on Britain's free vaccination list.In Australia the vaccine would need to be registered by the Therapeutic Goods Administration before being separately recommended for the national immunisation program.In the Lancet study, more than 1600 teenagers were given the vaccine or a placebo and 90 per cent showed immunity after one dose, rising to between 99 per cent and 100 per cent after two doses. Professors Elena Santolaya and L. O', from the University of Chile, who led the study, said it would be best to give two doses one and six months apart from two months. The study was funded by Novartis.The 4CMenB vaccine has been developed differently to the meningitis C vaccine and the researchers said the technique raised the possibility of creating one vaccine against all meningitis strains. They wrote: ''Further clinical data to support such an exciting prospect are needed.''Symptoms of meningitis include sudden onset of a high fever, a severe headache, aversion to bright lights, vomiting, painful joints, fitting, and drowsiness that can deteriorate into a coma.In babies the condition is harder to diagnose and symptoms include a fever while the hands and feet are cold, high-pitched moaning or whimpering, blank staring, inactivity, or being hard to wake, poor feeding, neck retraction and back arching, pale and blotchy complexion.If the bacteria enters the bloodstream septicaemia can develop, causing the characteristic rash often associated with meningitis.It may start as a cluster of pinprick blood spots under the skin, spreading to form bruises and can be distinguished by the fact that it does not fade when pressed under the bottom of a glass.with the Telegraph, London

Meryl Dorey,SpokespersonThe Australian Vaccination Network, Inc.Investigate before you vaccinateEditor,Living Wisdom MagazineFamily, Health, EnvironmentPO Box 177BANGALOW NSW 2479AUSTRALIAhttp://www.avn.org.auhttp://www.living-wisdom.comPhone: 02 6687 1699 FAX 02 6687 2032skype: ivmmagFreedom is not merely the opportunity to do as one pleases; neither is it merely the opportunity to choose between set alternatives. Freedom is, first of all, the chance to formulate the available choices, to argue over them -- and then, the opportunity to choose. - C. MillsThe authority of any governing institution must stop at its citizen's skin. - Gloria SteinemWe rely on the help and support of our members and subscribers to continue offering our services freely and without prejudice.Please consider helping us by subscribing to Living Wisdom and renewing your membership promptly if you are already an AVN member. Go to http://www.avn.org.au to subscribe or renew.We also sell books, videos and DVDs on vaccination and other health issues. Go to http://shop.avn.org.au/ for more details.PS - all of our subscriptions are currently on sale until December 24th. Our digital (online delivery) subscription is 50% off. Please check out the information at http://archive.constantcontact.com/fs082/1101800214009/archive/1108706073097.html